{"title":"Late-life disability may increase with more frequent insomnia symptoms and sleep medications use over time.","authors":"Tuo-Yu Chen, Soomi Lee, Orfeu M Buxton","doi":"10.1093/sleep/zsaf098","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objectives: </strong>This study investigated whether disability status increased with the frequency of insomnia symptoms and sleep medication usage over a 5-year period and whether frequent use of sleep medication modified the longitudinal effects of insomnia symptoms on disability among community-dwelling older adults.</p><p><strong>Methods: </strong>Data were from the National Health and Aging Trends Study (2011-2015; n = 6722). Disability was assessed with a validated disability index. Insomnia symptoms were assessed by the average frequency of longer sleep onset latency and trouble staying asleep. General sleep medication usage frequency was assessed. Multilevel modeling was used to analyze the data, considering health status, demographic information, and risky health behavior.</p><p><strong>Results: </strong>In the conditional growth model, for every one-unit higher in the frequency of insomnia symptoms and sleep medication usage, disability scores increased by 0.20 (SE = .02, p < .001) and 0.19 (SE = .02, p < .001) every year, respectively, adjusting for covariates. Moreover, the frequency of sleep medication usage influenced the relationship between insomnia symptoms and disability. Specifically, more frequent insomnia symptoms were associated with higher disability scores, and using sleep medications more often led to an even greater increase in disability scores than insomnia symptoms alone.</p><p><strong>Conclusions: </strong>Disability increased with more frequent insomnia symptoms and more frequent sleep medication usage each year. More frequent sleep medication usage has detrimental implications on disability beyond insomnia symptoms. Treating insomnia and managing sleep medication properly may help prevent disability among older adults.</p>","PeriodicalId":22018,"journal":{"name":"Sleep","volume":" ","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sleep/zsaf098","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Study objectives: This study investigated whether disability status increased with the frequency of insomnia symptoms and sleep medication usage over a 5-year period and whether frequent use of sleep medication modified the longitudinal effects of insomnia symptoms on disability among community-dwelling older adults.
Methods: Data were from the National Health and Aging Trends Study (2011-2015; n = 6722). Disability was assessed with a validated disability index. Insomnia symptoms were assessed by the average frequency of longer sleep onset latency and trouble staying asleep. General sleep medication usage frequency was assessed. Multilevel modeling was used to analyze the data, considering health status, demographic information, and risky health behavior.
Results: In the conditional growth model, for every one-unit higher in the frequency of insomnia symptoms and sleep medication usage, disability scores increased by 0.20 (SE = .02, p < .001) and 0.19 (SE = .02, p < .001) every year, respectively, adjusting for covariates. Moreover, the frequency of sleep medication usage influenced the relationship between insomnia symptoms and disability. Specifically, more frequent insomnia symptoms were associated with higher disability scores, and using sleep medications more often led to an even greater increase in disability scores than insomnia symptoms alone.
Conclusions: Disability increased with more frequent insomnia symptoms and more frequent sleep medication usage each year. More frequent sleep medication usage has detrimental implications on disability beyond insomnia symptoms. Treating insomnia and managing sleep medication properly may help prevent disability among older adults.
期刊介绍:
SLEEP® publishes findings from studies conducted at any level of analysis, including:
Genes
Molecules
Cells
Physiology
Neural systems and circuits
Behavior and cognition
Self-report
SLEEP® publishes articles that use a wide variety of scientific approaches and address a broad range of topics. These may include, but are not limited to:
Basic and neuroscience studies of sleep and circadian mechanisms
In vitro and animal models of sleep, circadian rhythms, and human disorders
Pre-clinical human investigations, including the measurement and manipulation of sleep and circadian rhythms
Studies in clinical or population samples. These may address factors influencing sleep and circadian rhythms (e.g., development and aging, and social and environmental influences) and relationships between sleep, circadian rhythms, health, and disease
Clinical trials, epidemiology studies, implementation, and dissemination research.